TCT 2018 | RADIOSOUND-HTN: Testing Different Renal Ablation Techniques and Devices

The clinical efficacy of renal endothelial sympathetic denervation using both radiofrequency and ultrasound endoscopy in the treatment of hypertension has already been proven. This is the first work comparing different techniques and technologies used to this end, which warranted its publication in Circulation.

Intentando reducir la insuficiencia renal post TAVIPatients with resistant hypertension were randomized 1:1:1 to: 1) radiofrequency denervation of the main renal arteries; 2) radiofrequency denervation of the main renal arteries, side branches, and accessories, or 3) ultrasound denervation of the main renal arteries. The primary endpoint was modification of systolic daytime ambulatory blood pressure at 3 months.

 

The study included 120 patients with mean daytime blood pressure 153/86 ± 12/13 mmHg.

 

At 3 months, systolic daytime blood pressure fell by 9.5 ± 12.3 mmHg in the whole cohort.


Read also: TCT 2018 | NEOPRO: A Registry for Acurate neo and Evolut PRO.


The drop in blood pressure was more significant in the ultrasound-guided group.

 

In patients with resistant hypertension, renal denervation using endovascular ultrasound proved to be superior to radiofrequency ablation, while the combined denervation of side branches and accessories resulted in no significant difference as regards outcomes compared with radiofrequency of the main renal arteries only.

 

Original title: A Three-Arm Randomized Trial of Different Renal Denervation Devices and Techniques in Patients with Resistant Hypertension: (RADIOSOUND-HTN).

Presenter: Philipp Lurz.

 

RADIOSOUND-HTN-presentación

RADIOSOUND-HTN-articulo-original


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

TCT 2024 | SIRONA: Randomized Study Comparing Sirolimus-Coated vs Paclitaxel-Coated Balloon Angioplasty in Femoropopliteal Disease

This prospective, randomized, multicenter, investigator-initiated non-inferiority study compared the use of sirolimus-coated balloon (MagicTouch) vs paclitaxel-coated balloon in endovascular treatment.  The primary objective was to...

TCT 2024 | PEERLESS: Mechanical Thrombectomy with FlowTriever vs Catheter-Directed Thrombolysis in Intermediate Risk PTE

Pulmonary embolism (PE) continues to be the third cause of cardiovascular mortality. The current clinical guidelines recommend anticoagulation in intermediate risk patients presenting right...

Atherosclerotic Renal Artery Stenosis: To Revascularize or Not

At long term, atherosclerotic renal artery stenosis (RAS) can lead to hypertension, chronic kidney disease, and cardiac failure. Historically, these patients have been referred...

Endovascular Management of Chronic TEPH: Is Coronary Management Extrapolatable in This Scenario?

Chronic thromboembolic pulmonary hypertension (CTEPH) is a condition that causes significant functional limitation. Its surgical treatment, known as pulmonary endarterectomy (PEA), has improved the...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 | TRISCEND II

This randomized study included 400 patients; 267 were treated with EVOQUE valve and 133 with optimal medical treatment (OMT). After one-year follow-up, there were no...

TCT 2024 – ACCESS-TAVI: Comparing Percutaneous Access Closure Strategies After TAVI

Vascular access complications following transcatheter aortic valve implantation (TAVI) remain common. However, few studies compare vascular access closure methods.  Based on the CHOICE-CLOSURE and MASH...